Showing results (11-20 of 100) with videos related to
Sort By:
Pageof 10
Nephron. Clinical Practice|December 5, 2008
A comparison of the predictive performance of different methods of kidney function estimation in a well-characterized HIV-infected populationKatherine Barraclough, Lee Er, Francisco Ng, et al.The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|June 2, 2010
Canadian consensus guidelines for the optimal use of etravirine in the treatment of HIV-infected adultsMarianne Harris, Jonathan B Angel, Jean-Guy Baril, et al.AIDS Research and Treatment|November 30, 2012
Cost-Effectiveness of Antiretroviral Therapy for Multidrug-Resistant HIV: Past, Present, and FutureMarianne Harris, Bohdan Nosyk, Richard Harrigan, et al.AIDS (London, England)|August 13, 2002
Consecutive rebounds in plasma viral load are associated with virological failure at 52 weeks among HIV-infected patientsJanet M Raboud, Sandra Rae, Ryan Woods, et al.AIDS Research and Therapy|November 4, 2017
HIV treatment simplification to elvitegravir/cobicistat/emtricitabine/tenofovir disproxil fumarate (E/C/F/TDF) plus darunavir: a pharmacokinetic studyMarianne Harris, Bruce Ganase, Birgit Watson, et al.The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|April 18, 2008
Canadian Consensus Recommendations for the Optimal Use of Enfuvirtide in HIV/AIDS PatientsAnita Rachlis, Jonathan Angel, Marianne Harris, et al.Journal of Clinical Pharmacology|January 31, 2009
Lopinavir/ritonavir pharmacokinetics in a substitution of high-dose soft-gelatin capsule to tablet formulationMark W Hull, Marianne Harris, Viviane Lima, et al.The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|December 2, 2011
Canadian consensus guidelines for the optimal use of maraviroc in the treatment of HIV-infected adultsAnita Rachlis, Marianne Harris, Richard Lalonde, et al.HIV Clinical Trials|January 31, 2002
Case series assessing the safety of mycophenolate as part of multidrug rescue treatment regimensNatasha Press, Gil Kimel, Marianne Harris, et al.AIDS (London, England)|July 7, 2023
Adherence to oral antiretroviral therapy in Canada, 2010-2020Jonathan B Angel, Jonatan Freilich, Erin Arthurs, et al.Pageof 10